• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像中的肿瘤坏死可预测肌层浸润性膀胱癌中的具有鳞状分化的尿路上皮癌。

Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma.

机构信息

Department of Radiology, Armed Forces Daejeon Hospital, Daejeon, South Korea.

Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Abdom Radiol (NY). 2024 Dec;49(12):4341-4351. doi: 10.1007/s00261-024-04317-5. Epub 2024 Aug 2.

DOI:10.1007/s00261-024-04317-5
PMID:39090259
Abstract

PURPOSE

This study investigated radiologic features on preoperative MRI to differentiate urothelial carcinoma with squamous differentiation (UCSD) from conventional urothelial carcinoma (UC) in muscle-invasive bladder carcinoma.

METHODS

Ninety-nine patients who underwent radical cystectomy and a preoperative bladder MRI scan within three months before surgery were retrospectively enrolled. Various MRI features, including tumor length, location, multiplicity, long-to-short axis ratio, morphology, radiologic stage, and degree of severe necrosis, were analyzed. Univariable and multivariable logistic regression analyses were performed to identify MRI features predictive of UCSD. The diagnostic performance of a significant MRI feature was assessed using 5-fold cross-validation.

RESULTS

Among the MRI features, significant radiologic findings associated with UCSD in the univariable analysis included heterogeneous tumor signal intensity in T2-weighted images (odds ratio [OR], 3.365; 95% confidence interval [CI], 1.213-9.986; P = 0.022) and contrast-enhanced T1-weighted images (OR, 4.428; 95% CI, 1.519-12.730; P = 0.007), as well as marked (≥ 50%) severe necrosis (OR, 17.100; 95% CI, 4.699-73.563; P < 0.001). In the multivariable analysis, marked (≥ 50%) severe necrosis (odds ratio [OR], 13.755; 95% confidence interval [CI], 2.796-89.118; P = 0.004) was a significant predictor of UCSD. Marked (≥ 50%) severe necrosis showed a high specificity of 95.0% with a precision of 65.0% for diagnosing UCSD based on 5-fold cross-validation.

CONCLUSION

Preoperative bladder MRI revealing marked severe necrosis may be indicative of UCSD and can assist in distinguishing it from conventional UC.

摘要

目的

本研究旨在探讨术前 MRI 的影像学特征,以区分肌层浸润性膀胱癌中的尿路上皮癌伴鳞状分化(UCSD)与普通尿路上皮癌(UC)。

方法

回顾性分析了 99 例在术前三个月内行根治性膀胱切除术和术前膀胱 MRI 扫描的患者。分析了各种 MRI 特征,包括肿瘤长度、位置、多发性、长轴与短轴之比、形态、影像学分期和严重坏死程度。采用单变量和多变量逻辑回归分析来识别预测 UCSD 的 MRI 特征。使用 5 倍交叉验证评估显著 MRI 特征的诊断性能。

结果

在 MRI 特征中,单变量分析中与 UCSD 相关的显著影像学发现包括 T2 加权图像上不均匀的肿瘤信号强度(优势比 [OR],3.365;95%置信区间 [CI],1.213-9.986;P=0.022)和对比增强 T1 加权图像(OR,4.428;95%CI,1.519-12.730;P=0.007),以及明显(≥50%)严重坏死(OR,17.100;95%CI,4.699-73.563;P<0.001)。在多变量分析中,明显(≥50%)严重坏死(OR,13.755;95%置信区间 [CI],2.796-89.118;P=0.004)是 UCSD 的显著预测因子。基于 5 倍交叉验证,明显(≥50%)严重坏死对 UCSD 的诊断具有 95.0%的高特异性和 65.0%的精准度。

结论

术前膀胱 MRI 显示明显的严重坏死可能提示 UCSD,并有助于将其与普通 UC 区分开来。

相似文献

1
Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma.磁共振成像中的肿瘤坏死可预测肌层浸润性膀胱癌中的具有鳞状分化的尿路上皮癌。
Abdom Radiol (NY). 2024 Dec;49(12):4341-4351. doi: 10.1007/s00261-024-04317-5. Epub 2024 Aug 2.
2
MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma.基于 MRI 的自动化机器学习模型用于术前识别肌层浸润性膀胱癌的变异组织学。
Eur Radiol. 2024 Mar;34(3):1804-1815. doi: 10.1007/s00330-023-10137-w. Epub 2023 Sep 2.
3
Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.膀胱尿路上皮癌中鳞状分化的临床意义
Cancer Control. 2018 Jan-Dec;25(1):1073274818800269. doi: 10.1177/1073274818800269.
4
Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.基于膀胱影像报告和数据系统(VI-RADS)的多参数 MRI 鉴别肌层浸润性和非肌层浸润性膀胱癌。
Br J Radiol. 2019 Dec;92(1104):20190401. doi: 10.1259/bjr.20190401. Epub 2019 Oct 8.
5
The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.鳞状组织学对膀胱癌临床结局和 PD-L1 表达的意义。
Int J Surg Pathol. 2022 Feb;30(1):6-14. doi: 10.1177/10668969211027264. Epub 2021 Jun 28.
6
Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?术前膀胱成像报告和数据系统(VI-RADS)评分 5 可可靠识别膀胱癌的膀胱外延伸,并预测显著的膀胱切除术延迟时间:是否需要重新考虑局部进展性疾病患者行原发性经尿道膀胱肿瘤深度切除术?
BJU Int. 2020 Nov;126(5):610-619. doi: 10.1111/bju.15188. Epub 2020 Aug 17.
7
Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.基于膀胱影像学报告和数据系统的膀胱尿路上皮癌异型组织学的肌层侵犯评估中双参数与多参数磁共振成像的比较
Eur Urol Focus. 2024 Jan;10(1):131-138. doi: 10.1016/j.euf.2023.08.004. Epub 2023 Aug 25.
8
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?辅助化疗对根治性膀胱切除术治疗肌层浸润性膀胱癌伴不良特征和变异组织学患者的影响:组织学亚型重要吗?
Cancer. 2019 May 1;125(9):1449-1458. doi: 10.1002/cncr.31952. Epub 2019 Jan 8.
9
CT and MRI features of sarcomatoid urothelial carcinoma of the bladder and its differential diagnosis with conventional urothelial carcinoma.膀胱肉瘤样尿路上皮癌的 CT 和 MRI 特征及其与普通尿路上皮癌的鉴别诊断。
Cancer Imaging. 2024 Aug 2;24(1):102. doi: 10.1186/s40644-024-00748-x.
10
Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.多参数 MRI 对具有异型组织学的膀胱尿路上皮癌的影像学综述:要点和陷阱。
Abdom Radiol (NY). 2024 Aug;49(8):2797-2811. doi: 10.1007/s00261-024-04397-3. Epub 2024 Jun 7.

引用本文的文献

1
Predicting variant histology in bladder cancer: the role of multiparametric MRI and vesical imaging-reporting and data system (VI-RADS).预测膀胱癌的组织学变异:多参数磁共振成像及膀胱影像报告和数据系统(VI-RADS)的作用。
Abdom Radiol (NY). 2025 Mar 18. doi: 10.1007/s00261-025-04852-9.

本文引用的文献

1
6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.6毫米分流的经颈静脉肝内门体分流术用于治疗严重肝萎缩和静脉曲张出血患者。
Eur Radiol. 2024 Jul;34(7):4697-4707. doi: 10.1007/s00330-023-10346-3. Epub 2023 Nov 25.
2
Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma.根治性膀胱切除术治疗膀胱癌后,鳞癌与具有鳞化分化的尿路上皮癌的肿瘤学结局比较。
Clin Genitourin Cancer. 2022 Apr;20(2):148-154. doi: 10.1016/j.clgc.2021.12.011. Epub 2021 Dec 16.
3
Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens?
膀胱癌组织学亚型:哪些参数可预测膀胱肿瘤经尿道切除术与根治性膀胱切除术标本之间的一致性?
Cent European J Urol. 2021;74(3):355-361. doi: 10.5173/ceju.2021.140.R1. Epub 2021 Sep 9.
4
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.纳武利尤单抗辅助治疗与安慰剂用于肌肉浸润性尿路上皮癌。
N Engl J Med. 2021 Jun 3;384(22):2102-2114. doi: 10.1056/NEJMoa2034442.
5
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.阿替利珠单抗辅助治疗与观察用于肌层浸润性尿路上皮癌(IMvigor010):一项多中心、开放标签、随机、III 期临床试验。
Lancet Oncol. 2021 Apr;22(4):525-537. doi: 10.1016/S1470-2045(21)00004-8. Epub 2021 Mar 12.
6
Comprehensive pathological assessment of histological subtypes, molecular subtypes based on immunohistochemistry, and tumor-associated immune cell status in muscle-invasive bladder cancer.全面病理评估浸润性膀胱癌的组织学亚型、免疫组织化学分子亚型和肿瘤相关免疫细胞状态。
Pathol Int. 2021 Mar;71(3):173-182. doi: 10.1111/pin.13060. Epub 2021 Jan 27.
7
The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.根治性膀胱切除术治疗的膀胱尿路上皮癌患者中组织学亚型对肿瘤学结局的影响。
Anticancer Res. 2020 Aug;40(8):4787-4793. doi: 10.21873/anticanres.14481.
8
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南:2020 年指南摘要。
Eur Urol. 2021 Jan;79(1):82-104. doi: 10.1016/j.eururo.2020.03.055. Epub 2020 Apr 29.
9
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review.膀胱癌的尿路上皮和非尿路上皮组织学变异对肌层浸润性和转移性膀胱癌患者的肿瘤学结局的预测价值及临床重要性如何?欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南小组系统评价。
Eur Urol Oncol. 2019 Nov;2(6):625-642. doi: 10.1016/j.euo.2019.09.003. Epub 2019 Oct 8.
10
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies.PD-L1 表达在以主要或纯变异组织学为特征的尿路上皮癌中的研究:3 种常用且市售的抗体之间的一致性。
Am J Surg Pathol. 2019 Jul;43(7):920-927. doi: 10.1097/PAS.0000000000001264.